Announcement

Collapse
No announcement yet.

Welcome to our forum! Before posting your questions, please read the following terms:

  1. 1. Forum questions will be responded to by InfantRisk staff as schedules permit during normal business hours.
  2. 2. This forum is not intended for emergencies or urgent care. For any immediate medical concerns, please seek appropriate medical attention.
  3. 3. Any statements made by team members should be discussed with your medical care team. Your healthcare providers know you (and your baby) best, and should have a better understanding of your unique situation.
  4. 4. We are a small team dedicated to helping you as best as we can. However, for the quickest response, we recommend calling the InfantRisk Center at +1(806) 352-2519.

By posting to the forums, you acknowledge and agree to these terms.

The InfantRisk team

Cimzia

Collapse
X
Collapse
 
  • Page of 1
  • Filter
  • Time
  • Show
Clear All
new posts
Previous template Next
  • #1

    Cimzia

    Hi,
    I have ankylosing spondylitis and have been prescribed cimzia. 6 weeks ago I gave birth to a 29 week baby boy who is currently in the nicu. My body is flaring really bad and I don't know what to do, if I should take cimzia or not. I know that is "most likely" safe but I am hesitant to take chances with my son in the nicu. Please let me know or if there is something else I could take that would be safer. Thanks

    Sara
    Tags: None
  • #2
    Chachamcmuff,

    Cimza (certolizumab) is rated an L3-no data-probably compatible. No human studies have been done but animal studies have shown minimal transfer of certolizumab into milk and no antibodies were detected in the nursing pups. The molecular weight of this product is large and it is not likely to transfer into milk except maybe in the colostrum phase. I spoke with Dr Hale he advised this is probably a good choice for you since he thinks it will have minimal transfer. Monitor the infant for fever, weight gain, frequent infections. Dr Hale is going to begin research on this medication if you would be willing to participate in the study please contact the InfantRisk Center.

    Sandra Lovato R.N.
    InfantRisk Center
    806-352-2519

    Comment

    Previous template Next
    Working...
    X